Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · IEX Real-Time Price · USD
7.24
-0.08 (-1.09%)
At close: Jul 19, 2024, 4:00 PM
7.31
+0.07 (0.97%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.23 billion as of July 22, 2024. Its market cap has increased by 147.17% in one year.
Market Cap
2.23B
Enterprise Value
4.93B
1-Year Change
147.17%
Ranking
Category
Stock Price
$7.24
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.23B, a decrease of -61.21%. That is a compound annual growth rate of -13.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 2.23B | 20.09% |
Dec 29, 2023 | 1.86B | 208.01% |
Dec 30, 2022 | 604.10M | -58.17% |
Dec 31, 2021 | 1.44B | 5.42% |
Dec 31, 2020 | 1.37B | -4.99% |
Dec 31, 2019 | 1.44B | -64.31% |
Dec 31, 2018 | 4.04B | -29.87% |
Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fortrea Holdings | 2.33B |
QuidelOrtho | 2.32B |
Janux Therapeutics | 2.32B |
Evolent Health | 2.29B |
Privia Health Group | 2.29B |
Iovance Biotherapeutics | 2.23B |
Patterson Companies | 2.20B |
CONMED | 2.19B |